|
1
|
Parkin DM, Pisani P and Ferlay J:
Estimates of the worldwide incidence of 25 major cancers in 1990.
Int J Cancer. 80:827–841. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neugut AI, Hayek M and Howe G:
Epidemiology of gastric cancer. Semin Oncol. 23:281–291.
1996.PubMed/NCBI
|
|
3
|
Hippo Y, Taniguchi H, Tsutsumi S, Machida
N, Chong JM, Fukayama M, Kodama T and Aburatani H: Global gene
expression analysis of gastric cancer by oligonucleotide
microarrays. Cancer Res. 62:233–240. 2002.PubMed/NCBI
|
|
4
|
Zhang X, Yashiro M, Ren J and Hirakawa K:
Histone deacetylase inhibitor, trichostatin A, increases the
chemosensitivity of anticancer drugs in gastric cancer cell lines.
Oncol Rep. 16:563–568. 2006.PubMed/NCBI
|
|
5
|
Wu ZQ, Zhang R, Chao C, Zhang JF and Zhang
YQ: Histone deacetylase inhibitor trichostatin A induced
caspase-independent apoptosis in human gastric cancer cell. Chin
Med J (Engl). 120:2112–2118. 2007.PubMed/NCBI
|
|
6
|
Lee HS, Park MH, Yang SJ, Jung HY, Byun
SS, Lee DS, Yoo HS, Yeom YI and Seo SB: Gene expression analysis in
human gastric cancer cell line treated with trichostatin A and
S-adenosyl-L-homocysteine using cDNA microarray. Biol Pharm Bull.
27:1497–1503. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zou XM, Li YL, Wang H, Cui W, Li XL, Fu SB
and Jiang HC: Gastric cancer cell lines induced by trichostatin A.
World J Gastroenterol. 14:4810–4815. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Friedgen B, Wölfel R, Russ H, Schömig E
and Graefe KH: The role of extraneuronal amine transport systems
for the removal of extracellular catecholamines in the rabbit.
Naunyn Schmiedebergs Arch Pharmacol. 354:275–286. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen H, Tini M and Evans RM: HATs on and
beyond chromatin. Curr Opin Cell Biol. 13:218–224. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Strahl BD, Briggs SD, Brame CJ, Caldwell
JA, Koh SS, Ma H, Cook RG, Shabanowitz J, Hunt DF, Stallcup MR and
Allis CD: Methylation of histone H4 at arginine 3 occurs in vivo
and is mediated by the nuclear receptor coactivator PRMT1. Curr
Biol. 11:996–1000. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheung WL, Briggs SD and Allis CD:
Acetylation and chromosomal functions. Curr Opin Cell Biol.
12:326–333. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshida M, Kijima M, Akita M and Beppu T:
Potent and specific inhibition of mammalian histone deacetylase
both in vivo and in vitro by trichostatin A. J Biol Chem.
265:17174–17179. 1990.PubMed/NCBI
|
|
13
|
Finnin MS, Donigian JR, Cohen A, Richon
VM, Rifkind RA, Marks PA, Breslow R and Pavletich NP: Structures of
a histone deacetylase homologue bound to the TSA and SAHA
inhibitors. Nature. 401:188–193. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kosugi H, Towatari M, Hatano S, Kitamura
K, Kiyoi H, Kinoshita T, Tanimoto M, Murate T, Kawashima K, Saito H
and Naoe T: Histone deacetylase inhibitors are the potent
inducer/enhancer of differentiation in acute myeloid leukemia: a
new approach to anti-leukemia therapy. Leukemia. 13:1316–1324.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yekutieli D and Benjamini Y:
Resampling-based false discovery rate controlling multiple test
procedures for correlated test statistics. J Stat Plan Infer.
82:171–196. 1999. View Article : Google Scholar
|
|
17
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: two different approaches for gene ontology
analysis. BMC Proc. 3:(Suppl 4). S102009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
da W Huang, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
19
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Papadopoulos GL, Reczko M, Simossis VA,
Sethupathy P and Hatzigeorgiou AG: The database of experimentally
supported targets: a functional update of TarBase. Nucleic Acids
Res. 37:(Database issue). D155–D158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garcia DM, Baek D, Shin C, Bell GW,
Grimson A and Bartel DP: Weak seed-pairing stability and high
target-site abundance decrease the proficiency of lsy-6 and other
microRNAs. Nat Struct Mol Biol. 18:1139–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao F, Zuo Z, Cai G, Kang S, Gao X and Li
T: miRecords: an integrated resource for microRNA-target
interactions. Nucleic Acids Res. 37:(Database issue). D105–D110.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: a
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang JH, Zhao LF, Lin P, Su XR, Chen SJ,
Huang LQ, Wang HF, Zhang H, Hu ZF, Yao KT and Huang ZX: GenCLiP
2.0: a web server for functional clustering of genes and
construction of molecular networks based on free terms.
Bioinformatics. 30:2534–2536. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu YP, Bian XJ, Ye DW, Yao XD, Zhang SL,
Dai B, Zhang HL and Shen YJ: Long noncoding RNA expression
signatures of bladder cancer revealed by microarray. Oncol Lett.
7:1197–1202. 2014.PubMed/NCBI
|
|
26
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao DL, Ye DW, Zhang HL, Zhu Y, Wang YX
and Yao XD: A multiplex model of combining gene-based,
protein-based, and metabolite-based with positive and negative
markers in urine for the early diagnosis of prostate cancer.
Prostate. 71:700–710. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang C, Li X, Wang Y, Zhao L and Chen W:
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB
through PI3-K dependent pathway in bladder carcinoma cells. Gene.
496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu Y, Yu M and Li Z, Kong C, Bi J, Li J,
Gao Z and Li Z: ncRAN, a newly identified long noncoding RNA,
enhances human bladder tumor growth, invasion, and survival.
Urology. 77(510): e1–e5. 2011.PubMed/NCBI
|
|
33
|
Perroud B, Lee J, Valkova N, Dhirapong A,
Lin PY, Fiehn O, Kültz D and Weiss RH: Pathway analysis of kidney
cancer using proteomics and metabolic profiling. Mol Cancer.
5:642006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gmeiner WH, Hellmann GM and Shen P:
Tissue-dependent and independent gene expression changes in
metastatic colon cancer. Oncol Rep. 19:245–251. 2008.PubMed/NCBI
|
|
35
|
Yang Q, Shen SS, Zhou S, Ni J, Chern D,
Wang G and Li Y: STAT3 activation and aberrant ligand-dependent
sonic hedgehog signaling in human pulmonary adenocarcinoma. Exp Mol
Pathol. 93:227–236. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gonzalez-Angulo AM, Iwamoto T, Liu S, Chen
H, Do KA, Hortobagyi GN, Mills GB, Meric-Bernstam F, Symmans WF and
Pusztai L: Gene expression, molecular class changes, and pathway
analysis after neoadjuvant systemic therapy for breast cancer. Clin
Cancer Res. 18:1109–1119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hirata H, Hinoda Y, Nakajima K, Kawamoto
K, Kikuno N, Ueno K, Yamamura S, Zaman MS, Khatri G, Chen Y, et al:
Wnt antagonist DKK1 acts as a tumor suppressor gene that induces
apoptosis and inhibits proliferation in human renal cell carcinoma.
Int J Cancer. 128:1793–1803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee J, Yoon YS and Chung JH: Epigenetic
silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell
lines. Gynecol Oncol. 109:270–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sato H, Suzuki H, Toyota M, Nojima M,
Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, et
al: Frequent epigenetic inactivation of DICKKOPF family genes in
human gastrointestinal tumors. Carcinogenesis. 28:2459–2466. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang H, Li Q and Chen H: Genistein affects
histone modifications on Dickkopf-related protein 1 (DKK1) gene in
SW480 human colon cancer cell line. PLoS One. 7:e409552012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yamabuki T, Takano A, Hayama S, Ishikawa
N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, et al:
Dikkopf-1 as a novel serologic and prognostic biomarker for lung
and esophageal carcinomas. Cancer Res. 67:2517–2525. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sheng SL, Huang G, Yu B and Qin WX:
Clinical significance and prognostic value of serum Dickkopf-1
concentrations in patients with lung cancer. Clin Chem.
55:1656–1664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Park H, Jung HY, Choi HJ, Kim DY, Yoo JY,
Yun CO, Min JK, Kim YM and Kwon YG: Distinct roles of DKK1 and DKK2
in tumor angiogenesis. Angiogenesis. 17:221–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Katzenellenbogen BS: Estrogen receptors:
bioactivities and interactions with cell signaling pathways. Biol
Reprod. 54:287–293. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Katzenellenbogen BS, Montano MM, Ekena K,
Herman ME and McInerney EM: William L. McGuire memorial lecture.
Antiestrogens: mechanisms of action and resistance in breast
cancer. Breast Cancer Res Treat. 44:23–38. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen X, Johns DC, Geiman DE, Marban E,
Dang DT, Hamlin G, Sun R and Yang VW: Krüppel-like factor 4
(gut-enriched Krüppel-like factor) inhibits cell proliferation by
blocking G1/S progression of the cell cycle. J Biol Chem.
276:30423–30428. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nemer M and Horb ME: The KLF family of
transcriptional regulators in cardiomyocyte proliferation and
differentiation. Cell Cycle. 6:117–121. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kaczynski J, Cook T and Urrutia R: Sp1-
and Krüppel-like transcription factors. Genome Biol. 4:2062003.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Henson BJ and Gollin SM: Overexpression of
KLF13 and FGFR3 in oral cancer cells. Cytogenet Genome Res.
128:192–198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and krüppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dang DT, Mahatan CS, Dang LH, Agboola IA
and Yang VW: Expression of the gut-enriched Krüppel-like factor
(Krüppel-like factor 4) gene in the human colon cancer cell line
RKO is dependent on CDX2. Oncogene. 20:4884–4890. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Miller KA, Eklund EA, Peddinghaus ML, Cao
Z, Fernandes N, Turk PW, Thimmapaya B and Weitzman SA: Kruppel-like
factor 4 regulates laminin alpha 3A expression in mammary
epithelial cells. J Biol Chem. 276:42863–42868. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Martin KM, Ellis PD, Metcalfe JC and Kemp
PR: Selective modulation of the SM22alpha promoter by the binding
of BTEB3 (basal transcription element-binding protein 3) to TGGG
repeats. Biochem J. 375:457–463. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lavallée G, Andelfinger G, Nadeau M,
Lefebvre C, Nemer G, Horb ME and Nemer M: The Kruppel-like
transcription factor KLF13 is a novel regulator of heart
development. EMBO J. 25:5201–5213. 2006. View Article : Google Scholar : PubMed/NCBI
|
